{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:33:52Z","timestamp":1791074032727,"version":"4.1.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T00:00:00Z","timestamp":1265673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00018-010-0265-2","type":"journal-article","created":{"date-parts":[[2010,2,8]],"date-time":"2010-02-08T16:27:28Z","timestamp":1265646448000},"page":"1293-1306","source":"Crossref","is-referenced-by-count":33,"title":["The corticotropin releasing factor system in cancer: expression and pathophysiological implications"],"prefix":"10.1007","volume":"67","author":[{"given":"Athina","family":"Kaprara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Pazaitou-Panayiotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Kortsaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterini","family":"Chatzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,9]]},"reference":[{"key":"265_CR1","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1073\/pnas.78.10.6517","volume":"78","author":"J Spiess","year":"1981","unstructured":"Spiess J, Rivier J, Rivier C, Vale W (1981) Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci USA 78:6517\u20136521","journal-title":"Proc Natl Acad Sci USA"},{"key":"265_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(01)01391-7","volume":"430","author":"S Pohl","year":"2001","unstructured":"Pohl S, Darlison MG, Clarke WC, Lederis K, Richter D (2001) Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish. Eur J Pharmacol 430:193\u2013202","journal-title":"Eur J Pharmacol"},{"key":"265_CR3","doi-asserted-by":"crossref","unstructured":"Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM, Vale WW (1996) Cloning and characterization of human urocortin published erratum appears in endocrinology 1996 Sep; 137(9):3896. Endocrinology 137:2167\u201370","DOI":"10.1210\/endo.137.5.8612563"},{"key":"265_CR4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/endo-57-5-599","volume":"57","author":"R Guillemin","year":"1955","unstructured":"Guillemin R, Rosenberg B (1955) Humoral hypothalamic control of anterior pituitary: a study with combined tissue cultures. Endocrinology 57:599\u2013607","journal-title":"Endocrinology"},{"key":"265_CR5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1139\/o55-054","volume":"33","author":"M Saffran","year":"1955","unstructured":"Saffran M, Schally AV (1955) The release of corticotrophin by anterior pituitary tissue in vitro. Can J Biochem Physiol 33:408\u2013415","journal-title":"Can J Biochem Physiol"},{"key":"265_CR6","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.6267699","volume":"213","author":"W Vale","year":"1981","unstructured":"Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213:1394\u20131397","journal-title":"Science"},{"key":"265_CR7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1471-4159.1996.67020482.x","volume":"67","author":"K Takahashi","year":"1996","unstructured":"Takahashi K, Hara E, Suzuki H, Sasano H, Shibahara S (1996) Expression of heme oxygenase isozyme mRNAs in the human brain and induction of heme oxygenase-1 by nitric oxide donors. J Neurochem 67:482\u2013489","journal-title":"J Neurochem"},{"key":"265_CR8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/378287a0","volume":"378","author":"J Vaughan","year":"1995","unstructured":"Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor see comments. Nature 378:287\u2013292","journal-title":"Nature"},{"key":"265_CR9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/87936","volume":"7","author":"SY Hsu","year":"2001","unstructured":"Hsu SY, Hsueh AJ (2001) Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7:605\u2013611","journal-title":"Nat Med"},{"key":"265_CR10","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1073\/pnas.051626398","volume":"98","author":"TM Reyes","year":"2001","unstructured":"Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE (2001) Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98:2843\u20132848","journal-title":"Proc Natl Acad Sci USA"},{"key":"265_CR11","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.1073\/pnas.121165198","volume":"98","author":"K Lewis","year":"2001","unstructured":"Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW (2001) Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98:7570\u20137575","journal-title":"Proc Natl Acad Sci USA"},{"key":"265_CR12","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1210\/jcem.82.11.4371","volume":"82","author":"K Iino","year":"1997","unstructured":"Iino K, Sasano H, Oki Y, Andoh N, Shin RW, Kitamoto T, Totsune K, Takahashi K, Suzuki H, Nagura H, Yoshimi T (1997) Urocortin expression in human pituitary gland and pituitary adenoma. J Clin Endocrinol Metab 82:3842\u20133850","journal-title":"J Clin Endocrinol Metab"},{"key":"265_CR13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0196-9781(98)00012-6","volume":"19","author":"K Takahashi","year":"1998","unstructured":"Takahashi K, Totsune K, Sone M, Murakami O, Satoh F, Arihara Z, Sasano H, Iino K, Mouri T (1998) Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain. Peptides 19:643\u2013647","journal-title":"Peptides"},{"key":"265_CR14","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0196-9781(00)00335-1","volume":"21","author":"Y Muramatsu","year":"2000","unstructured":"Muramatsu Y, Fukushima K, Iino K, Totsune K, Takahashi K, Suzuki T, Hirasawa G, Takeyama J, Ito M, Nose M, Tashiro A, Hongo M, Oki Y, Nagura H, Sasano H (2000) Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa. Peptides 21:1799\u20131809","journal-title":"Peptides"},{"key":"265_CR15","first-page":"1362","volume":"86","author":"Y Muramatsu","year":"2001","unstructured":"Muramatsu Y, Sugino N, Suzuki T, Totsune K, Takahashi K, Tashiro A, Hongo M, Oki Y, Sasano H (2001) Urocortin and corticotropin-releasing factor receptor expression in normal cycling human ovaries. J Clin Endocrinol Metab 86:1362\u20131369","journal-title":"J Clin Endocrinol Metab"},{"key":"265_CR16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/jcem.87.1.8160","volume":"87","author":"Y Kimura","year":"2002","unstructured":"Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H (2002) Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart. J Clin Endocrinol Metab 87:340\u2013346","journal-title":"J Clin Endocrinol Metab"},{"key":"265_CR17","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2003-031663","volume":"89","author":"K Takahashi","year":"2004","unstructured":"Takahashi K, Totsune K, Murakami O, Saruta M, Nakabayashi M, Suzuki T, Sasano H, Shibahara S (2004) Expression of urocortin III\/stresscopin in human heart and kidney. J Clin Endocrinol Metab 89:1897\u20131903","journal-title":"J Clin Endocrinol Metab"},{"key":"265_CR18","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.peptides.2005.01.014","volume":"26","author":"M Saruta","year":"2005","unstructured":"Saruta M, Takahashi K, Suzuki T, Fukuda T, Torii A, Sasano H (2005) Urocortin 3\/stresscopin in human colon: possible modulators of gastrointestinal function during stressful conditions. Peptides 26:1196\u20131206","journal-title":"Peptides"},{"key":"265_CR19","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.fertnstert.2006.05.041","volume":"86","author":"P Florio","year":"2006","unstructured":"Florio P, Torres PB, Torricelli M, Toti P, Vale W, Petraglia F (2006) Human endometrium expresses urocortin II and III messenger RNA and peptides. Fertil Steril 86:1766\u20131770","journal-title":"Fertil Steril"},{"key":"265_CR20","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1210\/endo.140.12.7223","volume":"140","author":"K Kageyama","year":"1999","unstructured":"Kageyama K, Bradbury MJ, Zhao L, Blount AL, Vale WW (1999) Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. Endocrinology 140:5651\u20135658","journal-title":"Endocrinology"},{"key":"265_CR21","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.peptides.2004.03.027","volume":"25","author":"T Suda","year":"2004","unstructured":"Suda T, Kageyama K, Sakihara S, Nigawara T (2004) Physiological roles of urocortins, human homologues of fish urotensin I, and their receptors. Peptides 25:1689\u20131701","journal-title":"Peptides"},{"key":"265_CR22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/74271","volume":"24","author":"T Kishimoto","year":"2000","unstructured":"Kishimoto T, Radulovic J, Radulovic M, Lin CR, Schrick C, Hooshmand F, Hermanson O, Rosenfeld MG, Spiess J (2000) Deletion of crhr2 reveals an anxiolytic role for corticotropin- releasing hormone receptor-2. Nat Genet 24:415\u2013419","journal-title":"Nat Genet"},{"key":"265_CR23","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1097\/00019616-199707011-00002","volume":"7","author":"WW Vale","year":"1997","unstructured":"Vale WW, Vaughn J, Perrin M (1997) Corticotropin-releasing factor (CRF) family of ligands and their receptors. Endocrinologist 7:3S\u20139S","journal-title":"Endocrinologist"},{"key":"265_CR24","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2174\/138955705774329500","volume":"5","author":"O Jahn","year":"2005","unstructured":"Jahn O, Radulovic J, Stiedl O, Tezval H, Eckart K, Spiess J (2005) Corticotropin-releasing factor binding protein\u2013a ligand trap? Mini Rev Med Chem 5:953\u2013960","journal-title":"Mini Rev Med Chem"},{"key":"265_CR25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/ajcp\/87.3.327","volume":"87","author":"SL Asa","year":"1987","unstructured":"Asa SL, Kovacs K, Vale W, Petrusz P, Vecsei P (1987) Immunohistologic localization of corticotrophin-releasing hormone in human tumors. Am J Clin Pathol 87:327\u2013333","journal-title":"Am J Clin Pathol"},{"key":"265_CR26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1530\/acta.0.1190506","volume":"119","author":"A Fjellestad-Paulsen","year":"1988","unstructured":"Fjellestad-Paulsen A, Abrahamsson PA, Bjartell A, Grino M, Grimelius L, Hedeland H, Falkmer S (1988) Carcinoma of the prostate with Cushing\u2019s syndrome. A case report with histochemical and chemical demonstration of immunoreactive corticotropin-releasing hormone in plasma and tumoral tissue. Acta Endocrinol (Copenhagen) 119:506\u2013516","journal-title":"Acta Endocrinol (Copenhagen)"},{"key":"265_CR27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2169\/internalmedicine.41.549","volume":"41","author":"Y Yamada","year":"2002","unstructured":"Yamada Y, Ohashi A, Inoue T, Sakaguchi K, Tsujimura T, Okamoto D, Itatani H, Fujimoto N, Kusaka K, Fushimi H (2002) Cushing\u2019s syndrome with a large pituitary adenoma producing both corticotropin-releasing hormone (CRH) and adrenocorticotropin (ACTH). Int Med 41:549\u2013554","journal-title":"Int Med"},{"key":"265_CR28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/pros.10094","volume":"52","author":"F Arcuri","year":"2002","unstructured":"Arcuri F, Cintorino M, Florio P, Floccari F, Pergola L, Romagnoli R, Petraglia F, Tosi P, Teresa Del Vecchio M (2002) Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma. Prostate 52:167\u2013172","journal-title":"Prostate"},{"key":"265_CR29","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1210\/jc.2002-021853","volume":"88","author":"JC Reubi","year":"2003","unstructured":"Reubi JC, Waser B, Vale W, Rivier J (2003) Expression of CRF1 and CRF2 receptors in human cancers. J Clin Endocrinol Metab 88:3312\u20133320","journal-title":"J Clin Endocrinol Metab"},{"key":"265_CR30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pros.20892","volume":"69","author":"H Tezval","year":"2009","unstructured":"Tezval H, Jurk S, Atschekzei F, Serth J, Kuczyk MA, Merseburger AS (2009) The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways. Prostate 69:443\u2013448","journal-title":"Prostate"},{"key":"265_CR31","first-page":"185","volume":"80","author":"A Makrigiannakis","year":"1995","unstructured":"Makrigiannakis A, Zoumakis E, Margioris AN, Theodoropoulos P, Stournaras C, Gravanis A (1995) The corticotropin-releasing hormone (CRH) in normal and tumoral epithelial cells of human endometrium. J Clin Endocrinol Metab 80:185\u2013189","journal-title":"J Clin Endocrinol Metab"},{"key":"265_CR32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1210\/endo.143.3.8694","volume":"143","author":"G Graziani","year":"2002","unstructured":"Graziani G, Tentori L, Portarena I, Barbarino M, Tringali G, Pozzoli G, Navarra P (2002) CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway. Endocrinology 143:807\u2013813","journal-title":"Endocrinology"},{"key":"265_CR33","first-page":"375","volume":"15","author":"G Graziani","year":"2006","unstructured":"Graziani G, Ferrandina G, Pozzoli G, Vergati M, Muzi A, Legge F, Tentori L, Scambia G, Navarra P (2006) Corticotropin-releasing hormone receptor-1 in human endometrial cancer. Oncol Rep 15:375\u2013379","journal-title":"Oncol Rep"},{"key":"265_CR34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1677\/joe.1.06726","volume":"190","author":"P Florio","year":"2006","unstructured":"Florio P, De Falco G, Leucci E, Torricelli M, Torres PB, Toti P, Dell\u2019Anna A, Tiso E, Santopietro R, Leoncini L, Petraglia F (2006) Urocortin expression is downregulated in human endometrial carcinoma. J Endocrinol 190:99\u2013105","journal-title":"J Endocrinol"},{"key":"265_CR35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.mce.2009.02.013","volume":"305","author":"F Miceli","year":"2009","unstructured":"Miceli F, Ranelletti FO, Martinelli E, Petrillo M, Scambia G, Navarra P, Ferrandina G (2009) Expression and subcellular localization of CRH and its receptors in human endometrial cancer. Mol Cell Endocrinol 305:6\u201311","journal-title":"Mol Cell Endocrinol"},{"key":"265_CR36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF01806354","volume":"15","author":"DR Ciocca","year":"1990","unstructured":"Ciocca DR, Puy LA, Fasoli LC, Tello O, Aznar JC, Gago FE, Papa SI, Sonego R (1990) Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients. Breast Cancer Res Treat 15:175\u2013184","journal-title":"Breast Cancer Res Treat"},{"key":"265_CR37","first-page":"1","volume":"12","author":"J Tjuvajev","year":"1998","unstructured":"Tjuvajev J, Kolesnikov Y, Joshi R, Sherinski J, Koutcher L, Zhou Y, Matei C, Koutcher J, Kreek MJ, Blasberg R (1998) Anti-neoplastic properties of human corticotropin releasing factor: involvement of the nitric oxide pathway. In Vivo 12:1\u201310","journal-title":"In Vivo"},{"key":"265_CR38","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1210\/en.2004-0194","volume":"145","author":"KL Parham","year":"2004","unstructured":"Parham KL, Zervou S, Karteris E, Catalano RD, Old RW, Hillhouse EW (2004) Promoter analysis of human corticotropin-releasing factor (CRF) type 1 receptor and regulation by CRF and urocortin. Endocrinology 145:3971\u20133983","journal-title":"Endocrinology"},{"key":"265_CR39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mce.2006.10.006","volume":"264","author":"G Graziani","year":"2007","unstructured":"Graziani G, Tentori L, Muzi A, Vergati M, Tringali G, Pozzoli G, Navarra P (2007) Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. Mol Cell Endocrinol 264:44\u201349","journal-title":"Mol Cell Endocrinol"},{"key":"265_CR40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1476-4598-8-30","volume":"8","author":"A Androulidaki","year":"2009","unstructured":"Androulidaki A, Dermitzaki E, Venihaki M, Karagianni E, Rassouli O, Andreakou E, Stournaras C, Margioris AN, Tsatsanis C (2009) Corticotropin releasing factor promotes breast cancer cell motility and invasiveness. Mol Cancer 8:30","journal-title":"Mol Cancer"},{"key":"265_CR41","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1530\/acta.0.1110546","volume":"111","author":"T Suda","year":"1986","unstructured":"Suda T, Tomori N, Yajima F, Odagiri E, Demura H, Shizume K (1986) Characterization of immunoreactive corticotropin and corticotropin: releasing factor in human adrenal and ovarian tumours. Acta Endocrinol (Copenhagen) 111:546\u2013552","journal-title":"Acta Endocrinol (Copenhagen)"},{"key":"265_CR42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/713602800","volume":"15","author":"E Zoumakis","year":"2001","unstructured":"Zoumakis E, Chatzaki E, Charalampopoulos I, Margioris AN, Angelakis E, Koumantakis E, Gravanis A (2001) Cycle and age-related changes in corticotropin-releasing hormone levels in human endometrium and ovaries. Gynecol Endocrinol 15:98\u2013102","journal-title":"Gynecol Endocrinol"},{"key":"265_CR43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.bjc.6603918","volume":"97","author":"V Minas","year":"2007","unstructured":"Minas V, Rolaki A, Kalantaridou SN, Sidiropoulos J, Mitrou S, Petsas G, Jeschke U, Paraskevaidis EA, Fountzilas G, Chrousos GP, Pavlidis N, Makrigiannakis A (2007) Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation. Br J Cancer 97:637\u2013645","journal-title":"Br J Cancer"},{"key":"265_CR44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ygcen.2005.10.014","volume":"146","author":"B Groef De","year":"2006","unstructured":"De Groef B, Van der Geyten S, Darras VM, Kuhn ER (2006) Role of corticotropin-releasing hormone as a thyrotropin-releasing factor in non-mammalian vertebrates. Gen Comp Endocrinol 146:62\u201368","journal-title":"Gen Comp Endocrinol"},{"key":"265_CR45","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1530\/acta.0.0830280","volume":"83","author":"JC Birkenhager","year":"1976","unstructured":"Birkenhager JC, Upton GV, Seldenrath HJ, Krieger DT, Tashjian AH Jr (1976) Medullary thyroid carcinoma: ectopic production of peptides with ACTH- like, corticotrophin releasing factor-like and prolactin production- stimulating activities. Acta Endocrinol (Copenhagen) 83:280\u2013292","journal-title":"Acta Endocrinol (Copenhagen)"},{"key":"265_CR46","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/1097-0142(19850301)55:5<995::AID-CNCR2820550513>3.0.CO;2-4","volume":"55","author":"I Wakabayashi","year":"1985","unstructured":"Wakabayashi I, Ihara T, Hattori M, Tonegawa Y, Shibasaki T, Hashimoto K (1985) Presence of corticotropin-releasing factor-like immunoreactivity in human tumors. Cancer 55:995\u20131000","journal-title":"Cancer"},{"key":"265_CR47","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000022079","volume":"45","author":"E Delgrange","year":"1999","unstructured":"Delgrange E, Maiter D, Donckier J, Tourniaire J (1999) Influence of age on the clinical presentation of prolactinomas in male patients. Gerontology 45:160\u2013164","journal-title":"Gerontology"},{"key":"265_CR48","first-page":"1159","volume":"145","author":"CD Scopa","year":"1994","unstructured":"Scopa CD, Mastorakos G, Friedman TC, Melachrinou M, Merino MJ, Chrousos GP (1994) Presence of immunoreactive corticotropin releasing hormone in thyroid lesions. Am J Pathol 145:1159\u20131167","journal-title":"Am J Pathol"},{"key":"265_CR49","first-page":"41","volume":"38","author":"M Tagliabue","year":"1996","unstructured":"Tagliabue M, Pagani A, Palestini N, Manieri C, Martina V (1996) Multiple endocrine neoplasia (MEN IIB) with Cushing\u2019s syndrome due to medullary thyroid carcinoma producing corticotropin-releasing hormone. Panminerva Med 38:41\u201344","journal-title":"Panminerva Med"},{"key":"265_CR50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF03401514","volume":"7","author":"A Chrisoulidou","year":"2008","unstructured":"Chrisoulidou A, Pazaitou-Panayiotou K, Georgiou E, Boudina M, Kontogeorgos G, Iakovou I, Efstratiou I, Patakiouta F, Vainas I (2008) Ectopic Cushing\u2019s syndrome due to CRH secreting liver metastasis in a patient with medullary thyroid carcinoma. Hormones (Athens) 7:259\u2013262","journal-title":"Hormones (Athens)"},{"key":"265_CR51","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/MAJ.0b013e31815200f8","volume":"335","author":"K Kageyama","year":"2008","unstructured":"Kageyama K, Sakihara S, Yamashita M, Takahashi K, Kawashima S, Tanabe J, Tsutaya S, Yasujima M, Suda T (2008) A case of multiple endocrine neoplasia type II accompanied by thyroid medullary carcinoma and pheochromocytomas expressing corticotropin-releasing factor and urocortins. Am J Med Sci 335:398\u2013402","journal-title":"Am J Med Sci"},{"key":"265_CR52","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.2741\/1966","volume":"11","author":"A Slominski","year":"2006","unstructured":"Slominski A, Zbytek B, Zmijewski M, Slominski RM, Kauser S, Wortsman J, Tobin DJ (2006) Corticotropin releasing hormone and the skin. Front Biosci 11:2230\u20132248","journal-title":"Front Biosci"},{"key":"265_CR53","first-page":"1020","volume":"83","author":"A Slominski","year":"1998","unstructured":"Slominski A, Ermak G, Mazurkiewicz JE, Baker J, Wortsman J (1998) Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab 83:1020\u20131024","journal-title":"J Clin Endocrinol Metab"},{"key":"265_CR54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-5793(98)01067-9","volume":"435","author":"N Fazal","year":"1998","unstructured":"Fazal N, Slominski A, Choudhry MA, Wei ET, Sayeed MM (1998) Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Lett 435:187\u2013190","journal-title":"FEBS Lett"},{"key":"265_CR55","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1749-6632.1999.tb08696.x","volume":"885","author":"Y Funasaka","year":"1999","unstructured":"Funasaka Y, Sato H, Ichihashi M (1999) Expression of corticotropin releasing hormone in malignant melanoma. Ann N Y Acad Sci 885:391\u2013393","journal-title":"Ann N Y Acad Sci"},{"key":"265_CR56","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1034\/j.1600-0749.2002.1o063.x","volume":"15","author":"H Sato","year":"2002","unstructured":"Sato H, Nagashima Y, Chrousos GP, Ichihashi M, Funasak Y (2002) The expression of corticotropin-releasing hormone in melanoma. Pigment Cell Res 15:98\u2013103","journal-title":"Pigment Cell Res"},{"key":"265_CR57","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-2133.2006.07442.x","volume":"155","author":"MH Kim","year":"2006","unstructured":"Kim MH, Cho D, Kim HJ, Chong SJ, Lee KH, Yu DS, Park CJ, Lee JY, Cho BK, Park HJ (2006) Investigation of the corticotropin-releasing hormone-proopiomelanocortin axis in various skin tumours. Br J Dermatol 155:910\u2013915","journal-title":"Br J Dermatol"},{"key":"265_CR58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0625.2006.00511.x","volume":"16","author":"Y Yang","year":"2007","unstructured":"Yang Y, Park H, Yang Y, Kim TS, Bang SI, Cho D (2007) Enhancement of cell migration by corticotropin-releasing hormone through ERK1\/2 pathway in murine melanoma cell line, B16F10. Exp Dermatol 16:22\u201327","journal-title":"Exp Dermatol"},{"key":"265_CR59","first-page":"1173","volume":"21","author":"KW Carlson","year":"2001","unstructured":"Carlson KW, Nawy SS, Wei ET, Sadee W, Filov VA, Rezsova VV, Slominski A, Quillan JM (2001) Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs. Anticancer Res 21:1173\u20131179","journal-title":"Anticancer Res"},{"key":"265_CR60","first-page":"232","volume":"22","author":"T Tsuchihashi","year":"1992","unstructured":"Tsuchihashi T, Yamaguchi K, Abe K, Yanaihara N, Saito S (1992) Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors. Jpn J Clin Oncol 22:232\u2013237","journal-title":"Jpn J Clin Oncol"},{"key":"265_CR61","first-page":"64","volume":"11","author":"M Bahro","year":"1992","unstructured":"Bahro M, Pfeifer U, Dammrich J (1992) Involvement of autophagic degradation in ACTH-induced skeletal muscle atrophy. Clin Neuropathol 11:64\u201370","journal-title":"Clin Neuropathol"},{"key":"265_CR62","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF03347737","volume":"17","author":"RJ Auchus","year":"1994","unstructured":"Auchus RJ, Mastorakos G, Friedman TC, Chrousos GP (1994) Corticotropin-releasing hormone production by a small cell carcinoma in a patient with ACTH-dependent Cushing\u2019s syndrome. J Endocrinol Invest 17:447\u2013452","journal-title":"J Endocrinol Invest"},{"key":"265_CR63","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1172\/JCI116898","volume":"92","author":"T Suda","year":"1993","unstructured":"Suda T, Tozawa F, Dobashi I, Horiba N, Ohmori N, Yamakado M, Yamada M, Demura H (1993) Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin- producing tumors in vitro. J Clin Invest 92:2790\u20132795","journal-title":"J Clin Invest"},{"key":"265_CR64","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF03347837","volume":"18","author":"AE Calogero","year":"1995","unstructured":"Calogero AE, Polosa R, Neville E, D\u2019Agata R (1995) Measurements of hormonal peptides in the bronchoalveolar fluid as tumor markers of lung cancer. J Endocrinol Invest 18:354\u2013358","journal-title":"J Endocrinol Invest"},{"key":"265_CR65","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF03344929","volume":"15","author":"AE Calogero","year":"1992","unstructured":"Calogero AE, Minacapilli G, Nicolosi AM, Moncada ML, Mistretta A, Latteri SF, Polosa P, D\u2019Agata R (1992) Limited clinical usefulness of plasma corticotropin-releasing hormone, adrenocorticotropin and beta-endorphin measurements as markers of lung cancer. J Endocrinol Invest 15:581\u2013586","journal-title":"J Endocrinol Invest"},{"key":"265_CR66","first-page":"59","volume":"108","author":"KD Dieterich","year":"2000","unstructured":"Dieterich KD, Lehnert H (2000) Decreased expression of corticotropin-releasing factor-binding protein mRNA in ACTH-secreting pituitary adenomas. Exp Clin Endocrinol Diabetes 108:59\u201362","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"265_CR67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0196-9781(94)90013-2","volume":"15","author":"TW Moody","year":"1994","unstructured":"Moody TW, Zia F, Venugopal R, Korman LY, Goldstein AL, Fagarasan M (1994) Corticotropin-releasing factor stimulates cyclic AMP, arachidonic acid release, and growth of lung cancer cells. Peptides 15:281\u2013285","journal-title":"Peptides"},{"key":"265_CR68","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mus.20899","volume":"37","author":"JM Argiles","year":"2008","unstructured":"Argiles JM, Figueras M, Ametller E, Fuster G, Olivan M, de Oliveira CC, Lopez-Soriano FJ, Isfort RJ, Busquets S (2008) Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells. Muscle Nerve 37:190\u2013195","journal-title":"Muscle Nerve"},{"key":"265_CR69","doi-asserted-by":"crossref","unstructured":"Paschos KA, Charsou C, Constantinidis TC, Anagnostoulis S, Lambropoulou M, Papachristou F, Simopoulos K, Chatzaki E (2010) Corticotropin releasing hormone receptors mediate opposing effects in cholestasis-induced liver cell apoptosis. Endocrinology (in press)","DOI":"10.1210\/en.2009-1208"},{"key":"265_CR70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-2007-948212","volume":"115","author":"SY Park","year":"2007","unstructured":"Park SY, Rhee Y, Youn JC, Park YN, Lee S, Kim DM, Song SY, Lim SK (2007) Ectopic Cushing\u2019s syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma. Exp Clin Endocrinol Diabetes 115:13\u201316","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"265_CR71","doi-asserted-by":"crossref","unstructured":"Simopoulos C, Christodoulou E, Lambropoulou M, Tsaroucha AK, Kakolyris S, Polychronidis A, Karayiannakis AJ, Chatzaki E (2009) Neuropeptide urocortin 1 and its receptors expressed human liver. Neuroendocrinology 89:315\u2013326","DOI":"10.1159\/000187136"},{"key":"265_CR72","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/07357900701788106","volume":"26","author":"J Wang","year":"2008","unstructured":"Wang J, Xu Y, Xu Y, Zhu H, Zhang R, Zhang G, Li S (2008) Urocortin\u2019s inhibition of tumor growth and angiogenesis in hepatocellular carcinoma via corticotrophin-releasing factor receptor 2. Cancer Invest 26:359\u2013368","journal-title":"Cancer Invest"},{"key":"265_CR73","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1471-4159.2004.02490.x","volume":"90","author":"E Chatzaki","year":"2004","unstructured":"Chatzaki E, Crowe PD, Wang L, Million M, Tache Y, Grigoriadis DE (2004) CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon. J Neurochem 90:309\u2013316","journal-title":"J Neurochem"},{"key":"265_CR74","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1210\/jcem.86.9.7827","volume":"86","author":"M Kohno","year":"2001","unstructured":"Kohno M, Kawahito Y, Tsubouchi Y, Hashiramoto A, Yamada R, Inoue KI, Kusaka Y, Kubo T, Elenkov IJ, Chrousos GP, Kondo M, Sano H (2001) Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. J Clin Endocrinol Metab 86:4344\u20134352","journal-title":"J Clin Endocrinol Metab"},{"key":"265_CR75","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0196-9781(01)00639-8","volume":"23","author":"T Kozicz","year":"2002","unstructured":"Kozicz T, Arimura A (2002) Distribution of urocortin in the rat\u2019s gastrointestinal tract and its colocalization with tyrosine hydroxylase. Peptides 23:515\u2013521","journal-title":"Peptides"},{"key":"265_CR76","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1210\/jc.2002-020853","volume":"88","author":"E Chatzaki","year":"2003","unstructured":"Chatzaki E, Charalampopoulos I, Leontidis C, Mouzas IA, Tzardi M, Tsatsanis C, Margioris AN, Gravanis A (2003) Urocortin in human gastric mucosa: relationship to inflammatory activity. J Clin Endocrinol Metab 88:478\u2013483","journal-title":"J Clin Endocrinol Metab"},{"key":"265_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2003.02078.x","volume":"88","author":"E Chatzaki","year":"2004","unstructured":"Chatzaki E, Murphy BJ, Wang L, Million M, Ohning GV, Crowe PD, Petroski R, Tache Y, Grigoriadis DE (2004) Differential profile of CRF receptor distribution in the rat stomach and duodenum assessed by newly developed CRF receptor antibodies. J Neurochem 88:1\u201311","journal-title":"J Neurochem"},{"key":"265_CR78","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/jcp.20792","volume":"209","author":"E Chatzaki","year":"2006","unstructured":"Chatzaki E, Lambropoulou M, Constantinidis TC, Papadopoulos N, Tache Y, Minopoulos G, Grigoriadis DE (2006) Corticotropin-releasing factor (CRF) receptor type 2 in the human stomach: Protective biological role by inhibition of apoptosis. J Cell Physiol 209:905\u2013911","journal-title":"J Cell Physiol"},{"key":"265_CR79","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1210\/mend.14.1.0403","volume":"14","author":"F Lezoualc\u2019h","year":"2000","unstructured":"Lezoualc\u2019h F, Engert S, Berning B, Behl C (2000) Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non- amyloidogenic amyloid beta precursor protein and with the suppression of nuclear factor-kappaB. Mol Endocrinol 14:147\u2013159","journal-title":"Mol Endocrinol"},{"key":"265_CR80","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1074\/jbc.M313063200","volume":"279","author":"KP Karalis","year":"2004","unstructured":"Karalis KP, Venihaki M, Zhao J, van Vlerken LE, Chandras C (2004) NF-kappaB participates in the corticotropin-releasing, hormone-induced regulation of the pituitary proopiomelanocortin gene. J Biol Chem 279:10837\u201310840","journal-title":"J Biol Chem"},{"key":"265_CR81","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10571-006-9040-1","volume":"26","author":"EM Smith","year":"2006","unstructured":"Smith EM, Gregg M, Hashemi F, Schott L, Hughes TK (2006) Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes. Cell Mol Neurobiol 26:1021\u20131036","journal-title":"Cell Mol Neurobiol"},{"key":"265_CR82","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1210\/me.2001-0334","volume":"16","author":"J Zhao","year":"2002","unstructured":"Zhao J, Karalis KP (2002) Regulation of nuclear factor-kappaB by corticotropin-releasing hormone in mouse thymocytes. Mol Endocrinol 16:2561\u20132570","journal-title":"Mol Endocrinol"},{"key":"265_CR83","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1677\/JME-08-0120","volume":"42","author":"M Huang","year":"2009","unstructured":"Huang M, Kempuraj D, Papadopoulou N, Kourelis T, Donelan J, Manola A, Theoharides TC (2009) Urocortin induces interleukin-6 release from rat cardiomyocytes through p38 MAP kinase, ERK and NF-kappa B activation. J Mol Endocrinol 42:397\u2013405","journal-title":"J Mol Endocrinol"},{"key":"265_CR84","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygcen.2007.01.046","volume":"153","author":"M Yao","year":"2007","unstructured":"Yao M, Denver RJ (2007) Regulation of vertebrate corticotropin-releasing factor genes. Gen Comp Endocrinol 153:200\u2013216","journal-title":"Gen Comp Endocrinol"},{"key":"265_CR85","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF01552870","volume":"2","author":"NC Vamvakopoulos","year":"1994","unstructured":"Vamvakopoulos NC, Sioutopoulou TO (1994) Human corticotropin-releasing hormone receptor gene (CRHR) is located on the long arm of chromosome 17 (17q12-qter). Chromosome Res 2:471\u2013473","journal-title":"Chromosome Res"},{"key":"265_CR86","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1210\/endo.140.4.6656","volume":"140","author":"CJ Rossant","year":"1999","unstructured":"Rossant CJ, Pinnock RD, Hughes J, Hall MD, McNulty S (1999) Corticotropin-releasing factor type 1 and type 2alpha receptors regulate phosphorylation of calcium\/cyclic adenosine 3\u2032, 5\u2032-monophosphate response element-binding protein and activation of p42\/p44 mitogen-activated protein kinase. Endocrinology 140:1525\u20131536","journal-title":"Endocrinology"},{"key":"265_CR87","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1210\/me.2003-0365","volume":"18","author":"N Papadopoulou","year":"2004","unstructured":"Papadopoulou N, Chen J, Randeva HS, Levine MA, Hillhouse EW, Grammatopoulos DK (2004) Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity. Mol Endocrinol 18:624\u2013639","journal-title":"Mol Endocrinol"},{"key":"265_CR88","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1677\/joe.0.1720283","volume":"172","author":"BK Brar","year":"2002","unstructured":"Brar BK, Railson J, Stephanou A, Knight RA, Latchman DS (2002) Urocortin increases the expression of heat shock protein 90 in rat cardiac myocytes in a MEK1\/2-dependent manner. J Endocrinol 172:283\u2013293","journal-title":"J Endocrinol"},{"key":"265_CR89","doi-asserted-by":"crossref","first-page":"8508","DOI":"10.1074\/jbc.275.12.8508","volume":"275","author":"BK Brar","year":"2000","unstructured":"Brar BK, Jonassen AK, Stephanou A, Santilli G, Railson J, Knight RA, Yellon DM, Latchman DS (2000) Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J Biol Chem 275:8508\u20138514","journal-title":"J Biol Chem"},{"key":"265_CR90","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0022-2828(03)00244-X","volume":"35","author":"A Chanalaris","year":"2003","unstructured":"Chanalaris A, Lawrence KM, Stephanou A, Knight RD, Hsu SY, Hsueh AJ, Latchman DS (2003) Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia\/reoxygenation injury in rat neonatal cardiomyocytes. J Mol Cell Cardiol 35:1295\u20131305","journal-title":"J Mol Cell Cardiol"},{"key":"265_CR91","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/me.2006-0255","volume":"20","author":"A Punn","year":"2006","unstructured":"Punn A, Levine MA, Grammatopoulos DK (2006) Identification of signaling molecules mediating corticotropin-releasing hormone-R1alpha-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1\/2 but not p38 MAPK activation. Mol Endocrinol 20:3179\u20133195","journal-title":"Mol Endocrinol"},{"key":"265_CR92","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1210\/en.2008-1810","volume":"150","author":"C Chandras","year":"2009","unstructured":"Chandras C, Koutmani Y, Kokkotou E, Pothoulakis C, Karalis KP (2009) Activation of phosphatidylinositol 3-kinase\/protein kinase B by corticotropin-releasing factor in human monocytes. Endocrinology 150:4606\u20134614","journal-title":"Endocrinology"},{"key":"265_CR93","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0006-8993(92)91324-8","volume":"593","author":"MC Olianas","year":"1992","unstructured":"Olianas MC, Lampis G, Onali P (1992) Human Y-79 retinoblastoma cells express functional corticotropin- releasing hormone receptors. Brain Res 593:304\u2013306","journal-title":"Brain Res"},{"key":"265_CR94","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1471-4159.1995.64010402.x","volume":"64","author":"MC Olianas","year":"1995","unstructured":"Olianas MC, Lampis G, Onali P (1995) Human Y-79 retinoblastoma cells exhibit specific corticotropin-releasing hormone binding sites. J Neurochem 64:402\u2013407","journal-title":"J Neurochem"},{"key":"265_CR95","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1046\/j.1471-4159.1997.68062308.x","volume":"68","author":"RL Hauger","year":"1997","unstructured":"Hauger RL, Dautzenberg FM, Flaccus A, Liepold T, Spiess J (1997) Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: rapid and reversible homologous desensitization but prolonged recovery. J Neurochem 68:2308\u20132316","journal-title":"J Neurochem"},{"key":"265_CR96","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1471-4159.2007.05052.x","volume":"104","author":"E Gutknecht","year":"2008","unstructured":"Gutknecht E, Hauger RL, Van der Linden I, Vauquelin G, Dautzenberg FM (2008) Expression, binding, and signaling properties of CRF2(a) receptors endogenously expressed in human retinoblastoma Y79 cells: passage-dependent regulation of functional receptors. J Neurochem 104:926\u2013936","journal-title":"J Neurochem"},{"key":"265_CR97","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1124\/mol.108.050427","volume":"75","author":"E Gutknecht","year":"2009","unstructured":"Gutknecht E, Van der Linden I, Van Kolen K, Verhoeven KF, Vauquelin G, Dautzenberg FM (2009) Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling. Mol Pharmacol 75:648\u2013657","journal-title":"Mol Pharmacol"},{"key":"265_CR98","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0028-3908(00)00167-2","volume":"40","author":"FM Dautzenberg","year":"2001","unstructured":"Dautzenberg FM, Hauger RL (2001) G-protein-coupled receptor kinase 3- and protein kinase C-mediated desensitization of the PACAP receptor type 1 in human Y-79 retinoblastoma cells. Neuropharmacology 40:394\u2013407","journal-title":"Neuropharmacology"},{"key":"265_CR99","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1046\/j.1471-4159.2003.01594.x","volume":"84","author":"M Radulovic","year":"2003","unstructured":"Radulovic M, Hippel C, Spiess J (2003) Corticotropin-releasing factor (CRF) rapidly suppresses apoptosis by acting upstream of the activation of caspases. J Neurochem 84:1074\u20131085","journal-title":"J Neurochem"},{"key":"265_CR100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00213-004-2134-x","volume":"180","author":"A Post","year":"2005","unstructured":"Post A, Ohl F, Almeida OF, Binder EB, Rucker M, Welt S, Binder E, Holsboer F, Sillaber I (2005) Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919). Psychopharmacology (Berl) 180:150\u2013158","journal-title":"Psychopharmacology (Berl)"},{"key":"265_CR101","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0165-3806(97)00033-3","volume":"100","author":"I Halasz","year":"1997","unstructured":"Halasz I, Rittenhouse PA, Zorrilla EP, Redei E (1997) Sexually dimorphic effects of maternal adrenalectomy on hypothalamic corticotrophin-releasing factor, glucocorticoid receptor and anterior pituitary POMC mRNA levels in rat neonates. Brain Res Dev Brain Res 100:198\u2013204","journal-title":"Brain Res Dev Brain Res"},{"key":"265_CR102","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.2174\/092986706778521977","volume":"13","author":"E Chatzaki","year":"2006","unstructured":"Chatzaki E, Minas V, Zoumakis E, Makrigiannakis A (2006) CRF receptor antagonists: utility in research and clinical practice. Curr Med Chem 13:2751\u20132760","journal-title":"Curr Med Chem"},{"key":"265_CR103","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0893-133X(02)00299-3","volume":"27","author":"SC Heinrichs","year":"2002","unstructured":"Heinrichs SC, De Souza EB, Schulteis G, Lapsansky JL, Grigoriadis DE (2002) Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist. Neuropsychopharmacology 27:194\u2013202","journal-title":"Neuropsychopharmacology"},{"key":"265_CR104","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1093\/eurheartj\/ehm340","volume":"28","author":"ME Davis","year":"2007","unstructured":"Davis ME, Pemberton CJ, Yandle TG, Fisher SF, Lainchbury JG, Frampton CM, Rademaker MT, Richards M (2007) Urocortin 2 infusion in human heart failure. Eur Heart J 28:2589\u20132597","journal-title":"Eur Heart J"},{"key":"265_CR105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1042\/CS20050079","volume":"109","author":"ME Davis","year":"2005","unstructured":"Davis ME, Pemberton CJ, Yandle TG, Lainchbury JG, Rademaker MT, Nicholls MG, Frampton CM, Richards AM (2005) Effect of urocortin 1 infusion in humans with stable congestive cardiac failure. Clin Sci (Lond) 109:381\u2013388","journal-title":"Clin Sci (Lond)"},{"key":"265_CR106","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bbrc.2007.08.014","volume":"362","author":"J Wang","year":"2007","unstructured":"Wang J, Li S (2007) Corticotropin-releasing factor family and its receptors: tumor therapeutic targets? Biochem Biophys Res Commun 362:785\u2013788","journal-title":"Biochem Biophys Res Commun"},{"key":"265_CR107","first-page":"8","volume":"91","author":"Y Nishi","year":"2000","unstructured":"Nishi Y, Takayanagi R, Yanase T, Haji M, Hasegawa Y, Nawata H (2000) Inhibin-like immunoreactivity produced by the adrenal gland is circulating in vivo. Fukuoka Igaku Zasshi 91:8\u201320","journal-title":"Fukuoka Igaku Zasshi"},{"key":"265_CR108","first-page":"1103","volume":"146","author":"C Preeyasombat","year":"1992","unstructured":"Preeyasombat C, Sirikulchayanonta V, Mahachokelertwattana P, Sriphrapradang A, Boonpucknavig S (1992) Cushing\u2019s syndrome caused by Ewing\u2019s sarcoma secreting corticotropin releasing factor-like peptide. Am J Dis Child 146:1103\u20131105","journal-title":"Am J Dis Child"},{"key":"265_CR109","doi-asserted-by":"crossref","unstructured":"Makrigiannakis A, Margioris AN, Chatzaki E, Zoumakis E, Chrousos GP, Gravanis A (1999) The decidualizing effect of progesterone may involve direct transcriptional activation of corticotrophin-releasing hormone from human endometrial stromal cells. Mol Hum Reprod 5:789\u2013796","DOI":"10.1093\/molehr\/5.9.789"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-010-0265-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-010-0265-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-010-0265-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T14:23:00Z","timestamp":1558534980000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-010-0265-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,9]]},"references-count":109,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["265"],"URL":"https:\/\/doi.org\/10.1007\/s00018-010-0265-2","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,9]]}}}